These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8520274)

  • 21. Hormone therapies in women aged 40 and older: prevalence and correlates of use.
    Carney PA; Tosteson AN; Titus-Ernstoff L; Weiss JE; Goodrich ME; Manganiello P; Kasales CJ
    Maturitas; 2006 Jan; 53(1):65-76. PubMed ID: 16325024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General practitioners use of hormone-replacement therapy in Yorkshire.
    Bryce FC; Lilford RJ
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):55-61. PubMed ID: 2376279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attitudes of Norwegian general practitioners to prescription of estrogens 1990-92].
    Hunskår S; Hannestad YS; Backe B; Matheson I
    Tidsskr Nor Laegeforen; 1994 Aug; 114(18):2095-8. PubMed ID: 7992263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
    Vallejo MS; Witis S; Ojeda E; Mostajo D; Morera F; Meruvia N; Martino M; Lima S; Espinoza MT; Castillo O; Campostrini B; Danckers L; Blümel JE; Tserotas K; Sánchez H; Salinas C; Saavedra J; Rojas JA; Onatra W; Monterrosa A; Montaño A; Martínez J; González E; Gómez G; Calle A; Broutin G; Bencosme A; Arteaga E; Ayala F; Chedraui P
    Climacteric; 2016 Aug; 19(4):387-92. PubMed ID: 27327136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of and satisfaction with complementary therapies and hormone replacement therapy in a specialist menopause clinic.
    Vashisht A; Domoney CL; Cronje W; Studd JW
    Climacteric; 2001 Sep; 4(3):250-6. PubMed ID: 11588949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
    Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
    Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy: a study of women's knowledge and attitudes.
    Sinclair HK; Bond CM; Taylor RJ
    Br J Gen Pract; 1993 Sep; 43(374):365-70. PubMed ID: 8251232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female OB/GYNs speak out about health practices.
    AWHONN Lifelines; 2004; 8(1):14-8. PubMed ID: 15031881
    [No Abstract]   [Full Text] [Related]  

  • 30. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis.
    Draper J; Roland M
    BMJ; 1990 Mar; 300(6727):786-8. PubMed ID: 2386562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-sectional national questionnaire survey assessing the clinical attitudes of members of the British Menopause Society to the management of women with premature ovarian insufficiency.
    Mittal M; Savvas M; Narvekar N; Panay N; Hamoda H
    Post Reprod Health; 2014 Sep; 20(3):90-7. PubMed ID: 24973048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scottish gynaecologists: their views on hormone replacement therapy.
    Campbell-Brown M; McEwan HP
    Health Bull (Edinb); 1992 May; 50(3):248-51. PubMed ID: 1506194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women doctors' use of hormone replacement therapy. High prevalence of use is not confined to doctors.
    Banks E; Crossley B; English R; Richardson A
    BMJ; 1996 Mar; 312(7031):638. PubMed ID: 8595357
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormone replacement therapy in Norwegian women, 1996-1997.
    Bakken K; Eggen AE; Lund E
    Maturitas; 2001 Nov; 40(2):131-41. PubMed ID: 11716991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.
    Constantine GD; Graham S; Clerinx C; Bernick BA; Krassan M; Mirkin S; Currie H
    Post Reprod Health; 2016 Sep; 22(3):112-22. PubMed ID: 26895640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
    Pinkerton JV; Santoro N
    Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal hormone therapy--benefits, adverse reactions, concerns and information sources in 2009.
    Tiihonen M; Saarela M; Saarinen S; Ahonen R; Heikkinen AM
    Maturitas; 2011 Sep; 70(1):69-73. PubMed ID: 21723053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.